IRIS Accounts Production v26.1.0.640 09778473 director 1.10.24 31.7.25 31.7.25 0 0 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh097784732024-09-30097784732025-07-31097784732024-10-012025-07-31097784732023-09-30097784732023-10-012024-09-30097784732024-09-3009778473ns15:EnglandWales2024-10-012025-07-3109778473ns14:PoundSterling2024-10-012025-07-3109778473ns10:Director12024-10-012025-07-3109778473ns10:PrivateLimitedCompanyLtd2024-10-012025-07-3109778473ns10:SmallEntities2024-10-012025-07-3109778473ns10:AuditExempt-NoAccountantsReport2024-10-012025-07-3109778473ns10:SmallCompaniesRegimeForDirectorsReport2024-10-012025-07-3109778473ns10:SmallCompaniesRegimeForAccounts2024-10-012025-07-3109778473ns10:FullAccounts2024-10-012025-07-3109778473ns10:OrdinaryShareClass12024-10-012025-07-3109778473ns10:OrdinaryShareClass22024-10-012025-07-3109778473ns10:RegisteredOffice2024-10-012025-07-3109778473ns5:CurrentFinancialInstruments2025-07-3109778473ns5:CurrentFinancialInstruments2024-09-3009778473ns5:Non-currentFinancialInstruments2025-07-3109778473ns5:Non-currentFinancialInstruments2024-09-3009778473ns5:ShareCapital2025-07-3109778473ns5:ShareCapital2024-09-3009778473ns5:RetainedEarningsAccumulatedLosses2025-07-3109778473ns5:RetainedEarningsAccumulatedLosses2024-09-3009778473ns5:ComputerEquipment2024-10-012025-07-3109778473ns5:FurnitureFittings2024-09-3009778473ns5:MotorVehicles2024-09-3009778473ns5:ComputerEquipment2024-09-3009778473ns5:FurnitureFittings2024-10-012025-07-3109778473ns5:MotorVehicles2024-10-012025-07-3109778473ns5:FurnitureFittings2025-07-3109778473ns5:MotorVehicles2025-07-3109778473ns5:ComputerEquipment2025-07-3109778473ns5:FurnitureFittings2024-09-3009778473ns5:MotorVehicles2024-09-3009778473ns5:ComputerEquipment2024-09-3009778473ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2024-10-012025-07-3109778473ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2025-07-3109778473ns5:WithinOneYearns5:CurrentFinancialInstruments2025-07-3109778473ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3009778473ns10:OrdinaryShareClass12025-07-3109778473ns10:OrdinaryShareClass22025-07-31
REGISTERED NUMBER: 09778473 (England and Wales)















Unaudited Financial Statements

for the Period 1 October 2024 to 31 July 2025

for

Waendel Diagnostics Limited

Waendel Diagnostics Limited (Registered number: 09778473)






Contents of the Financial Statements
for the Period 1 October 2024 to 31 July 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Waendel Diagnostics Limited

Company Information
for the Period 1 October 2024 to 31 July 2025







DIRECTOR: M J Annable





REGISTERED OFFICE: 5 Varley Close
Wellingborough
Northamptonshire
NN8 4UZ





REGISTERED NUMBER: 09778473 (England and Wales)





ACCOUNTANTS: CDA Accountancy
Unit 11/12 Hall Farm
Sywell Aerodrome
Sywell
Northamptonshire
NN6 0BN

Waendel Diagnostics Limited (Registered number: 09778473)

Balance Sheet
31 July 2025

31.7.25 30.9.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 40,902 208

CURRENT ASSETS
Debtors 5 6,674 9,156
Investments 6 2,450 2,450
Cash at bank 80,250 18,039
89,374 29,645
CREDITORS
Amounts falling due within one year 7 25,885 18,795
NET CURRENT ASSETS 63,489 10,850
TOTAL ASSETS LESS CURRENT
LIABILITIES

104,391

11,058

CREDITORS
Amounts falling due after more than
one year

8

31,390

-
NET ASSETS 73,001 11,058

CAPITAL AND RESERVES
Called up share capital 9 5,000 5,000
Retained earnings 68,001 6,058
SHAREHOLDERS' FUNDS 73,001 11,058

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 July 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 July 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Waendel Diagnostics Limited (Registered number: 09778473)

Balance Sheet - continued
31 July 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 May 2026 and were signed by:





M J Annable - Director


Waendel Diagnostics Limited (Registered number: 09778473)

Notes to the Financial Statements
for the Period 1 October 2024 to 31 July 2025

1. STATUTORY INFORMATION

Waendel Diagnostics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents gross invoiced sales, including value added tax. The company operates the flat rate scheme.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Computer equipment - 33% on cost

Financial instruments
The company is party to only basic financial instruments such as cash, trade debtors and creditors and loans. Instruments such as trade debtors and trade creditors are initially recognised at their transaction cost and reviewed at the year end for impairment. Debt instruments not repayable on demand or due within one year, such as bank loans, are measured at amortised cost using the effective interest rate.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Waendel Diagnostics Limited (Registered number: 09778473)

Notes to the Financial Statements - continued
for the Period 1 October 2024 to 31 July 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL (2024 - NIL).

4. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 October 2024 - - 2,626 2,626
Additions 1,173 49,804 707 51,684
At 31 July 2025 1,173 49,804 3,333 54,310
DEPRECIATION
At 1 October 2024 - - 2,418 2,418
Charge for period 244 10,376 370 10,990
At 31 July 2025 244 10,376 2,788 13,408
NET BOOK VALUE
At 31 July 2025 929 39,428 545 40,902
At 30 September 2024 - - 208 208

Waendel Diagnostics Limited (Registered number: 09778473)

Notes to the Financial Statements - continued
for the Period 1 October 2024 to 31 July 2025

4. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Motor
vehicles
£   
COST
Additions 49,804
At 31 July 2025 49,804
DEPRECIATION
Charge for period 10,376
At 31 July 2025 10,376
NET BOOK VALUE
At 31 July 2025 39,428

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.25 30.9.24
£    £   
Trade debtors 6,456 8,998
Prepayments 218 158
6,674 9,156

6. CURRENT ASSET INVESTMENTS
31.7.25 30.9.24
£    £   
Unlisted investments 2,450 2,450

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.25 30.9.24
£    £   
Hire purchase contracts 6,310 -
Trade creditors 1 172
Tax 15,794 12,415
VAT 2,030 4,300
Directors' current accounts - 278
Accrued expenses 1,750 1,630
25,885 18,795

Waendel Diagnostics Limited (Registered number: 09778473)

Notes to the Financial Statements - continued
for the Period 1 October 2024 to 31 July 2025

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
31.7.25 30.9.24
£    £   
Hire purchase contracts 31,390 -

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.7.25 30.9.24
value: £    £   
2,500 Ordinary A £1 2,500 2,500
2,500 Ordinary B £1 2,500 2,500
5,000 5,000